225 related articles for article (PubMed ID: 31904665)
1. Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S; Hasserjian RP; Hobbs G
Curr Opin Hematol; 2020 Mar; 27(2):122-127. PubMed ID: 31904665
[TBL] [Abstract][Full Text] [Related]
2. Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
Elsayed M; Harry S; Nanua S; Zaidi S; Habib MH; Raza S
Cureus; 2022 Jul; 14(7):e26619. PubMed ID: 35949766
[TBL] [Abstract][Full Text] [Related]
3. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
[TBL] [Abstract][Full Text] [Related]
4. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
[TBL] [Abstract][Full Text] [Related]
5. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N; Orazi A; Tefferi A
Am J Hematol; 2024 Apr; ():. PubMed ID: 38644693
[TBL] [Abstract][Full Text] [Related]
6. Current and evolving understanding of atypical chronic myeloid leukemia.
Schwartz LC; Mascarenhas J
Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
[TBL] [Abstract][Full Text] [Related]
7. Update on CML-Like Disorders.
Cross NCP
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S101-S102. PubMed ID: 32862848
[TBL] [Abstract][Full Text] [Related]
8. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A
Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic/myeloproliferative neoplasms.
Hyjek E; Vardiman JW
Semin Diagn Pathol; 2011 Nov; 28(4):283-97. PubMed ID: 22195406
[TBL] [Abstract][Full Text] [Related]
10. Atypical chronic myeloid leukemias.
Oscier D
Pathol Biol (Paris); 1997 Sep; 45(7):587-93. PubMed ID: 9404484
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
[TBL] [Abstract][Full Text] [Related]
13. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.
Kuendgen A; Kasprzak A; Germing U
Front Oncol; 2021; 11():778741. PubMed ID: 34869027
[TBL] [Abstract][Full Text] [Related]
14. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
Fend F; Horn T; Koch I; Vela T; Orazi A
Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
[TBL] [Abstract][Full Text] [Related]
15. Atypical chronic myeloid leukaemia, a distinct clinical entity related to the myelodysplastic syndrome?
Oscier DG
Br J Haematol; 1996 Mar; 92(3):582-6. PubMed ID: 8616021
[TBL] [Abstract][Full Text] [Related]
16. Atypical Chronic Myeloid Leukemia: Where Are We Now?
Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
[TBL] [Abstract][Full Text] [Related]
17. Atypical chronic myeloid leukaemia with trisomy 13: a case report.
Guo-yu H; Chao-hui Y; Kui T; Zhen-zhen C
Chin Med Sci J; 2011 Dec; 26(4):254-6. PubMed ID: 22218057
[TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
19. [BCR-ABL1 negative chronic myeloid leukemia: report of two cases].
Figueroa-Faúndez F; Vidal-Rojas C; Briones-Muñoz V; Chandía-Cabas M
Rev Med Chil; 2022 Mar; 150(3):397-401. PubMed ID: 36156725
[TBL] [Abstract][Full Text] [Related]
20. Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment.
Castellino A; Santambrogio E; Rapezzi D; Massaia M
Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
